4.8 Article

Human heart-forming organoids recapitulate early heart and foregut development

期刊

NATURE BIOTECHNOLOGY
卷 39, 期 6, 页码 737-746

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41587-021-00815-9

关键词

-

资金

  1. German Research Foundation (DFG) [EXC 62/2, ZW64/4-1, KFO311/ZW64/7-1, WA 2597/3-1, SFB/TRR152]
  2. German Ministry for Education and Science (BMBF) [13N14086, 01EK1601A, 01EK1602A, 13XP5092B, 031L0249, 82DZL00201, 82DZL00401]
  3. Forderung aus Mitteln des Niedersachsischen Vorab [ZN3340]
  4. European Union [66724]
  5. Cortiss Stiftung

向作者/读者索取更多资源

This study successfully generated three-dimensional heart-forming organoids that closely resemble early native heart anlagen, containing myocardial layer, endocardial-like cells, septum-transversum-like anlagen, and distinct anterior versus posterior foregut endoderm tissues. These organoids were used to study genetic defects in vitro and demonstrated a phenotype similar to cardiac malformations seen in transgenic mice with the knockout of NKX2.5 gene.
Heart-forming organoids model early cardiac development. Organoid models of early tissue development have been produced for the intestine, brain, kidney and other organs, but similar approaches for the heart have been lacking. Here we generate complex, highly structured, three-dimensional heart-forming organoids (HFOs) by embedding human pluripotent stem cell aggregates in Matrigel followed by directed cardiac differentiation via biphasic WNT pathway modulation with small molecules. HFOs are composed of a myocardial layer lined by endocardial-like cells and surrounded by septum-transversum-like anlagen; they further contain spatially and molecularly distinct anterior versus posterior foregut endoderm tissues and a vascular network. The architecture of HFOs closely resembles aspects of early native heart anlagen before heart tube formation, which is known to require an interplay with foregut endoderm development. We apply HFOs to study genetic defects in vitro by demonstrating that NKX2.5-knockout HFOs show a phenotype reminiscent of cardiac malformations previously observed in transgenic mice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cell & Tissue Engineering

High density bioprocessing of human pluripotent stem cells by metabolic control and in silico modeling

Felix Manstein, Kevin Ullmann, Christina Kropp, Caroline Halloin, Wiebke Triebert, Annika Franke, Clara-Milena Farr, Anais Sahabian, Alexandra Haase, Yannik Breitkreuz, Michael Peitz, Oliver Brustle, Stefan Kalies, Ulrich Martin, Ruth Olmer, Robert Zweigerdt

Summary: By combining STBR technology with in silico process modeling, challenges in hPSC production were overcome, leading to a rapid 70-fold increase in cell expansion and maintenance of cell quality stability.

STEM CELLS TRANSLATIONAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

Hypoxic Conditions Promote the Angiogenic Potential of Human Induced Pluripotent Stem Cell-Derived Extracellular Vesicles

Andre Cronemberger Andrade, Martin Wolf, Heide-Marie Binder, Fausto Gueths Gomes, Felix Manstein, Patricia Ebner-Peking, Rodolphe Poupardin, Robert Zweigerdt, Katharina Schallmoser, Dirk Strunk

Summary: The study found that the quantity of iPSC-EVs is influenced by oxygen conditions and the method of EV preparation, with the best recovery observed at 1% oxygen and significantly elevated angiogenic potential.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell & Tissue Engineering

Establishment of MHHi001-A-5, a GCaMP6f and RedStar dual reporter human iPSC line for in vitro and in vivo characterization and in situ tracing of iPSC derivatives

Alexandra Haase, Tim Kohrn, Veronika Fricke, Maria Elena Ricci Signorini, Merlin Witte, Gudrun Goehring, Ina Gruh, Ulrich Martin

Summary: This article describes a transgenic hiPSC line with dual reporter genes, which can be used to monitor engraftment, calcium fluctuations, and coupling of iPSC derivatives such as cardiomyocytes.

STEM CELL RESEARCH (2021)

Article Cell & Tissue Engineering

Generation of two iPSC clones (MHHi021-A and MHHi021-B) from a patient with hypertrophic cardiomyopathy with p.Arg723Gly mutation in the MYH7 gene

S. Merkert, S. Wunderlich, J. Beier, A. Franke, K. Schwanke, G. Gohring, T. Kraft, A. Francino, R. Zweigerdt, U. Martin

Summary: The study generated two iPSC clones from a HCM patient, heterozygous for the p.Arg723Gly mutation in the MYH7 gene, which could be valuable for investigating the pathogenesis of HCM.

STEM CELL RESEARCH (2021)

Correction Biotechnology & Applied Microbiology

Human heart-forming organoids recapitulate early heart and foregut development (Feb, 10.1038/s41587-021-00815-9, 2021)

Lika Drakhlis, Santoshi Biswanath, Clara-Milena Farr, Victoria Lupanow, Jana Teske, Katharina Ritzenhoff, Annika Franke, Felix Manstein, Emiliano Bolesani, Henning Kempf, Simone Liebscher, Katja Schenke-Layland, Jan Hegermann, Lena Nolte, Heiko Meyer, Jeanne de la Roche, Stefan Thiemann, Christian Wahl-Schott, Ulrich Martin, Robert Zweigerdt

NATURE BIOTECHNOLOGY (2021)

Article Chemistry, Analytical

Towards Biohybrid Lung: Induced Pluripotent Stem Cell Derived Endothelial Cells as Clinically Relevant Cell Source for Biologization

Michael Pflaum, Julia Dahlmann, Lena Engels, Hossein Naghilouy-Hidaji, Denise Adam, Janina Zoellner, Annette Otto, Sabrina Schmeckebier, Ulrich Martin, Axel Haverich, Ruth Olmer, Bettina Wiegmann

Summary: The study demonstrated the potential therapeutic effect of iPSC-derived endothelial cells (ECs) in forming a continuous, non-thrombogenic, and non-inflammatory monolayer on blood-contacting surfaces of biohybrid lung (BHL). These specific ECs could reduce platelet adhesion and repopulate scratched areas, showing promise for BHL application.

MICROMACHINES (2021)

Article Pharmacology & Pharmacy

Simplified 89Zr-Labeling Protocol of Oxine (8-Hydroxyquinoline) Enabling Prolonged Tracking of Liposome-Based Nanomedicines and Cells

Andras Polyak, Jens P. Bankstahl, Karen F. W. Besecke, Constantin Hozsa, Wiebke Triebert, Rajeswara Rao Pannem, Felix Manstein, Thomas Borcholte, Marcus Furch, Robert Zweigerdt, Robert K. Gieseler, Frank M. Bengel, Tobias L. Ross

Summary: This study optimized a method for the preparation of the highly lipophilic labeling synthon [Zr-89]Zr(oxinate)(4) for radiolabeling of liposomes and human induced pluripotent stem cells. The developed labeling protocol demonstrated high radiochemical yields and efficient cell internalization rates. Prolonged PET imaging confirmed the stability of labeled nanocarriers in vivo, emphasizing the potential of the method for drug delivery and cell therapy applications.

PHARMACEUTICS (2021)

Article Biochemical Research Methods

Continuous human iPSC-macrophage mass production by suspension culture in stirred tank bioreactors

Mania Ackermann, Anna Rafiei Hashtchin, Felix Manstein, Marco Carvalho Oliveira, Henning Kempf, Robert Zweigerdt, Nico Lachmann

Summary: This study presents a detailed protocol for mass production of iPSC-derived macrophages in scalable suspension culture or in STBRs, allowing for stable generation of functional and highly pure macrophages. The technology enables real-time monitoring of crucial process parameters, promoting systematic process development, optimization, and linear upscaling.

NATURE PROTOCOLS (2022)

Article Biochemistry & Molecular Biology

Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy

Denisa Bojkova, Rui Costa, Philipp Reus, Marco Bechtel, Mark-Christian Jaboreck, Ruth Olmer, Ulrich Martin, Sandra Ciesek, Martin Michaelis, Jindrich Cinatl

Summary: SARS-CoV-2 infection induces a metabolic shift towards glycolysis in host cells, with the glycolysis inhibitor 2DG being developed for COVID-19 treatment. Enhanced levels of transketolase (TKT) in infected cells suggest a role for the non-oxidative PPP, supported by the TKT inhibitor BOT inhibiting SARS-CoV-2 replication and synergizing with 2DG. Metabolic drugs like BOT and 2DG may improve COVID-19 therapy outcomes by targeting both viral replication and immunopathology.

METABOLITES (2021)

Article Hematology

Human iPSC-derived macrophages for efficient Staphylococcus aureus clearance in a murine pulmonary infection model

Anna Rafiei Hashtchin, Beate Fehlhaber, Miriam Hetzel, Felix Manstein, Jan Lennart Stalp, Silke Glage, Markus Abeln, Robert Zweigerdt, Antje Munder, Dorothee Viemann, Mania Ackermann, Nico Lachmann

Summary: Primary or secondary immunodeficiencies disrupt cellular and humoral immunity, leading to increased susceptibility to respiratory infections. Adoptive transfer of macrophages can enhance pulmonary immunity against Staphylococcus aureus, reducing bacterial load and tissue damage. Studies demonstrate that induced pluripotent stem cell-derived macrophages are more effective in combating S aureus infections compared to monocyte-derived macrophages.

BLOOD ADVANCES (2021)

Article Multidisciplinary Sciences

Airway basal cells show a dedifferentiated KRT17high Phenotype and promote fibrosis in idiopathic pulmonary fibrosis

Benedikt Jaeger, Jonas Christian Schupp, Linda Plappert, Oliver Terwolbeck, Gian Kayser, Peggy Engelhard, Taylor Sterling Adams, Robert Zweigerdt, Henning Kempf, Stefan Lienenklaus, Wiebke Garrels, Irina Nazarenko, Danny Jonigk, Malgorzata Wygrecka, Denise Klatt, Axel Schambach, Naftali Kaminski, Antje Prasse, Nataliia Artysh

Summary: This study focuses on the properties of airway basal cells (ABC) obtained from patients with idiopathic pulmonary fibrosis (IPF) and reveals the extensive reprogramming of IPF-ABC. The study also shows that IPF-ABC can induce fibroblast proliferation and extracellular matrix deposition in a 3D organoid model, and these changes can be reversed by SRC inhibition. The findings suggest that IPF-ABC and SRC inhibition may serve as potential targets for the treatment of IPF.

NATURE COMMUNICATIONS (2022)

Article Cell Biology

Primary Ciliary Dyskinesia Patient-Specific hiPSC-Derived Airway Epithelium in Air-Liquid Interface Culture Recapitulates Disease Specific Phenotypes In Vitro

Laura von Schledorn, David Puertollano Martin, Nicole Cleve, Janina Zoellner, Doris Roth, Ben Ole Staar, Jan Hegermann, Felix C. Ringshausen, Janna Nawroth, Ulrich Martin, Ruth Olmer

Summary: Primary ciliary dyskinesia (PCD) is a rare genetic disorder that affects the function of motile cilia in the respiratory tract, leading to chronic inflammation and lung damage. Current treatment options for PCD are only symptomatic, highlighting the need for curative therapies. In this study, researchers developed an in vitro model using human induced pluripotent stem cells (hiPSC) to recapitulate the diseased phenotype of PCD at the molecular, structural, and functional levels.
Article Cell Biology

An Improved Protocol for Targeted Differentiation of Primed Human Induced Pluripotent Stem Cells into HLA-G-Expressing Trophoblasts to Enable the Modeling of Placenta-Related Disorders

Ian O. Shum, Sylvia Merkert, Svitlana Malysheva, Kirsten Jahn, Nico Lachmann, Murielle Verboom, Helge Frieling, Michael Hallensleben, Ulrich Martin

Summary: Abnormalities during trophoblast development can lead to pregnancy-related complications, but the underlying mechanisms are established during the first trimester. Human pluripotent stem cell (hPSC) technology provides a renewable source of cells for studying these diseases. By optimizing the treatment protocol, we were able to generate trophoblast cells enriched for HLA-G(pos) EVT-like cells, which will aid in understanding placenta-related disorders and investigation of immune tolerance towards the fetus.
Article Biochemical Research Methods

Process control and in silico modeling strategies for enabling high density culture of human pluripotent stem cells in stirred tank bioreactors

Felix Manstein, Kevin Ullmann, Wiebke Triebert, Robert Zweigerdt

Summary: The protocol outlines controlled expansion of hPSCs in stirred tank bioreactors, achieving high cell densities while reducing culture medium consumption. It provides a detailed blueprint for systematic process development of hPSCs and their progenies.

STAR PROTOCOLS (2021)

暂无数据